Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Unstable Angina: later-stage trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Unstable Angina: 5 US clinical trials tracked, none currently recruiting.
Unstable Angina is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Johnson & Johnson Pharmaceutical Research & Development, L.L.C., running 1 of these trials.
Enrollment posture brief
Registry condition unstable-angina
OPEN 0 | RECR 0% | LATE 4 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Unstable Angina has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Unstable Angina on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Unstable Angina is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Unstable Angina research.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Unstable Angina enrolment sits around 406 participants.
Median target enrolment is 406 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Unstable Angina research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00809965
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
Sanofi
NCT00043784
Restore EF Observational Study
Abiomed
NCT04648306
Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
Massachusetts General Hospital
NCT00181818
Myocardial Ischemia and Transfusion Pilot
Rutgers, The State University of New Jersey
NCT01167582
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Unstable Angina records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Unstable Angina trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Unstable Angina page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Unstable Angina trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. sponsors the most Unstable Angina trials on record, review their full trial history before evaluating a specific study. See Johnson & Johnson Pharmaceutical Research & Development, L.L.C.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Unstable Angina condition card totals 5 registered trials; most-linked intervention Prophylactic Impella support for a non-emergent PCI; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.